Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
402.5 USD | +0.35% | +1.59% | -1.08% |
06/05 | Vertex Pharmaceuticals Q1 Non-GAAP EPS, Revenue Increase | MT |
06/05 | Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.08% | 104B | |
+9.15% | 105B | |
+5.79% | 22.94B | |
-11.55% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.91% | 16.96B | |
+7.55% | 14.16B | |
+40.04% | 12.63B | |
+320.26% | 8.49B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals : RBC Lifts Price Target on Vertex Pharmaceuticals to $248 From $246, Maintains Outperform Rating